Itemoids

Floridians

We’re About to Find Out How Much Americans Like Vaccines

The Atlantic

www.theatlantic.com › health › archive › 2024 › 11 › rfk-vaccination-rates › 680715

Sign up for Being Human, a newsletter that explores wellness culture, mortality and disease, and other mysteries of the body and the mind.

Robert F. Kennedy Jr., the nominee to be the next secretary of Health and Human Services, is America’s most prominent vaccine skeptic. An advocacy organization that he founded and chaired has called the nation’s declining child-immunization rates “good news,” and referred to parents’ lingering doubts about routine shots as COVID-19’s “silver lining.” Now Kennedy may soon be overseeing the cluster of federal agencies that license and recommend vaccines, as well as the multibillion-dollar program that covers the immunization of almost half the nation’s children.

Which is to say that America’s most prominent vaccine skeptic could have the power to upend, derail, or otherwise louse up a cornerstone of public health. Raising U.S. vaccination rates to where they are today took decades of investment: In 1991, for example, just 82 percent of toddlers were getting measles shots; by 2019, that number had increased to 92 percent. The first Trump administration actually presided over the historic high point for the nation’s immunization services; now the second may be focused on promoting vaccines’ alleged hidden harms. Kennedy has said that he doesn’t want to take any shots away, but even if he were to emphasize “choice,” his leadership would be a daunting test of Americans’ commitment to vaccines.

In many ways, the situation is unprecedented: No one with Kennedy’s mix of inexperience and paranoid distrust has ever held the reins at HHS. He was trained as a lawyer and has no training in biostatistics or any other research bona fides—the sorts of qualifications you’d expect from someone credibly evaluating vaccine efficacy. But the post-pandemic era has already given rise to at least one smaller-scale experiment along these lines. In Florida, vaccine policies have been overseen since 2021 by another noted skeptic of the pharmaceutical industry, State Surgeon General Joseph Ladapo. (Kennedy has likened Ladapo to Galileo—yes, the astronomer who faced down the Roman Inquisition.) Under Ladapo’s direction, the state has aggressively resisted federal guidance on COVID-19 vaccination, and its department of health has twice advised Floridians not to get mRNA-based booster shots. “These vaccines are not appropriate for use in human beings,” Ladapo declared in January. His public-health contrarianism has also started spilling over into more routine immunization practices. Last winter, during an active measles outbreak at a Florida school, Ladapo abandoned standard practice and allowed unvaccinated children to attend class. He also seemed to make a point of not recommending measles shots for any kids who might have needed them.

Jeffrey Goldhagen, a pediatrics professor at the University of Florida and the former head of the Duval County health department, believes that this vaccine skepticism has had immense costs. “The deaths and suffering of thousands and thousands of Floridians” can be linked to Ladapo’s policies, he said, particularly regarding COVID shots. But in the years since Ladapo took office, Florida did not become an instant outlier in terms of COVID vaccination numbers, nor in terms of age-adjusted rates of death from COVID. And so far at least, the state’s performance on other immunization metrics is not far off from the rest of America’s. That doesn’t mean Florida’s numbers are good: Among the state’s kindergarteners, routine-vaccination rates have dropped from 93.3 percent for the kids who entered school in the fall of 2020 to 88.1 percent in 2023, and the rate at which kids are getting nonmedical exemptions from vaccine requirements went up from 2.7 to 4.5 percent over the same period. These changes elevate the risk of further outbreaks of measles, or of other infectious diseases that could end up killing children—but they’re not unique to Ladapo’s constituents. National statistics have been moving in the same direction. (To wit: The rate of nonmedical exemptions across the U.S. has gone up by about the same proportion as Florida’s.)

All of these disturbing trends may be tied to a growing suspicion of vaccines that was brought on during COVID and fanned by right-wing influencers. Or they could be a lingering effect of the widespread lapse in health care in 2020, during which time many young children were missing doses of vaccines. (Kids who entered public school in 2023 might still be catching up.)

In any case, other vaccination rates in Florida look pretty good. Under Ladapo, the state has actually been gaining on the nation as a whole in terms of flu shots for adults and holding its own on immunization for diphtheria, tetanus, and pertussis in toddlers. Even Ladapo’s outlandish choice last winter to allow unvaccinated kids back into a school with an active measles outbreak did not lead to any further cases of disease. In short, as I noted back in February, Ladapo’s anti-vaccine activism has had few, if any, clear effects. (Ladapo did not respond when I reached out to ask why his policies might have failed to sabotage the state’s vaccination rates.)

  

If Florida’s immunization rates have been resilient, then America’s may hold up even better in the years to come. That’s because the most important vaccine policies are made at the state and local levels, Rupali Limaye, a professor and scholar of health behavior at Johns Hopkins University, told me. Each state decides whether and how to mandate vaccines to school-age children, or during a pandemic. The states and localities are then responsible for giving out (or choosing not to give out) whichever vaccines are recommended, and sometimes paid for, by the federal government.  

But the existence of vaccine-skeptical leadership in Washington, and throughout the Republican Party, could still end up putting pressure on local decision makers, she continued, and could encourage policies that support parental choice at the expense of maximizing immunization rates. As a member of the Cabinet, Kennedy would also have a platform that he’s never had before, from which he can continue to spread untruths about vaccines. “If you start to give people more of a choice, and they are exposed to disinformation and misinformation, then there is that propensity of people to make decisions that are not based on evidence,” Limaye said. (According to The New York Times, many experts say they “worry most” about this aspect of Kennedy’s leadership.)

How much will this really matter, though? The mere prominence of Kennedy’s ideas may not do much to drive down vaccination rates on its own. Noel Brewer, a behavioral scientist and public-health professor at the UNC Gillings School of Global Public Health, told me that attempts to change people’s thoughts and feelings about vaccines are often futile; research shows that talking up the value of getting shots has little impact on behavior. By the same token, one might reasonably expect that talking down the value of vaccines (as Kennedy and Ladapo are wont to do) would be wasted effort too. “It may be that having a public figure talking about this has little effect,” Brewer said.

Indeed, much has been made of Kennedy’s apparent intervention during the 2019 measles crisis in Samoa. He arrived there for a visit in the middle of that year, not long after measles immunizations had been suspended, and children’s immunization rates had plummeted. (The crisis began when two babies died from a vaccine-related medical error in 2018.) Kennedy has been linked to the deadly measles outbreak in the months that followed, but if his presence really did give succor to the local anti-vaccine movement, that movement’s broader aims were frustrated: The government declared a state of emergency that fall, and soon the measles-vaccination rate had more than doubled.

As head of HHS, though, Kennedy would have direct control over the federal programs that do the sort of work that has been necessary in Samoa, and provide access to vaccines to those who need them most. For example, he’d oversee the agencies that pay for and administer Vaccines for Children, which distributes shots to children in every state. All the experts I spoke with warned that interference with this program could have serious consequences. Other potential actions, such as demanding further safety studies of vaccines and evidence reviews, could slow down decision making and delay the introduction of new vaccines.

Kennedy would also have a chance to influence the nation’s vaccine requirements for children, as well as its safety-and-monitoring system, at the highest levels. He’d be in charge of selecting members for the Advisory Committee on Immunization Practices, which makes recommendations on vaccines that are usually adopted by the states and result in standardized insurance coverage. He’d also oversee the head of the CDC, who in turn has the authority to overrule or amend individual ACIP recommendations.

Even if he’s not inclined to squelch any determinations outright, Kennedy’s goal of giving parents latitude might play out in other ways. Brewer, who is currently a voting member of ACIP (but emphasized that he was not speaking in that capacity), said that the committee can issue several different types of rulings, some of which roughly correspond to ACIP saying that Americans should rather than may get a certain vaccine. That distinction can be very consequential, Brewer said: Shots that are made “routine” by ACIP get prioritized in doctor’s offices, for instance, while those that are subject to “shared clinical decision-making” may be held for patients who ask for them specifically. Shifting the country’s vaccination program from a should to a may regime “would destroy uptake,” Brewer told me.

Those would seem to be the stakes. The case study of vaccine-skeptical governance that we have in Florida may not look so dire—at least in the specifics. But Kennedy’s ascendancy could be something more than that: He could steer the public-health establishment off the course that it’s been on for many years, and getting back to where we are today could take more years still.

Democrats Actually Had Quite a Good Night in North Carolina

The Atlantic

www.theatlantic.com › politics › archive › 2024 › 11 › north-carolina-election-democrats-governor-legislature › 680570

Tuesday evening, while waiting for national election results to come in, I dropped by the victory party for Mark Robinson, the North Carolina Republican nominee for governor. It was, as you might expect, a strange scene.

Robinson, the lieutenant governor, had become persona non grata among most other Republicans in September, when a CNN report revealed his bizarre posts—about slavery, being a “Black Nazi,” transgender porn, and more—on the porn site Nude Africa. He was no longer invited to attend rallies for the Donald Trump campaign, his fundraising dried up, and his campaign was left for dead.

The party, held on the top floor of a skyscraper in Raleigh, was pointedly separate from other North Carolina GOP festivities. Some 60 or 70 supporters crammed into a small room in a private club watching Fox News. It was a more diverse crowd than any other Republican gathering I’ve ever attended, and nearly everyone was decked out in Robinson gear. I noticed only one piece of Trump swag, and a wide range of other fashion choices. A younger Black man wore a satin jacket with red-sequin embroidery; an older white guy wore a white tuxedo jacket, complete with bow tie, over a red Mark Robinson T-shirt.

Polls in North Carolina closed at 7:30 p.m. ET. Just a few minutes later, Fox News projected that the Democrat Josh Stein, the current state attorney general, would beat Robinson. I expected to hear jeers or a murmur or feel some deflation in the room, but nothing happened. I started wondering if I’d misread, but no: Fox repeated the call several times in the next few minutes, and eventually someone changed the channel to Spectrum News. I asked some attendees what they made of the news, and was told over and over that they had hope that the call was premature.

[David A. Graham: The great, disappearing Trump campaign]

This was not exactly a denial, and around 9, Robinson took the stage and conceded the race. “The window of opportunity for us to win this race is closing quick, folks,” he said. “Doesn’t seem like it’s going our way tonight. But it’s always going our way. Whether people want it to or not, people of faith know it’s going to go the right way, because we’ve read the back of the book. We know how this all comes to an end.” He barely alluded to the scandals that had sunk his campaign, saying, “It’s not about the lies; it’s not about the half-truths.” Soon, attendees began streaming out, clutching handfuls of campaign signs and hats.

It was a fittingly weird start to a weird night in North Carolina politics. The Old North State delivered a series of results that show why national Democrats have been so hopeful about flipping it, while likely discouraging them from trying again for some time.

Trump won the state in the presidential election. Kamala Harris received both a smaller percentage of the vote than President Joe Biden did four years ago and (in unofficial results) a smaller absolute number of votes. That all happened despite a massive campaign infrastructure and get-out-the-vote operation, especially as compared with the Trump campaign. In the deep-red counties where Harris had hoped to cut into Republican margins, she barely managed to move the ball or else lost ground. National Democrats poured money into the state, and once again, it broke their hearts.

Down the ballot, however, North Carolina Democrats had a good night. Stein beat Robinson by almost 15 points. That matches with some of the public polling on the race, but most insiders seemed to expect a margin closer to the high single-digits. The Democrat Rachel Hunt flipped the lieutenant governor’s seat. Jeff Jackson held off Dan Bishop for attorney general; no Republican has won the seat since the 19th century. Secretary of State Elaine Marshall won another term. For superintendent of public instruction, Mo Green beat Michele Morrow, who attended the January 6, 2021, rally and called for Barack Obama’s execution. In a heartbreaker for Democrats, state-supreme-court justice Allison Riggs appears to have lost her seat narrowly, but in the state legislature, Democrats broke a veto-proof Republican supermajority. U.S. Representative Don Davis eked out a win in northeastern North Carolina.

[David A. Graham: Mark Robinson is testing the bounds of GOP extremism]

One lesson from this is that North Carolina really is a purple state, as the political scientist Chris Cooper describes in a new book. Voters are happy to elect Democrats at the state level; they just don’t want them in the White House or the U.S. Senate. (The last election North Carolinians selected a Democrat for either was in 2008.)

Across the country, the election looks similar—more a repudiation of national Democrats, and especially the Democratic candidate for president, than a rejection of Democratic policy priorities. (I argued yesterday that Trump’s simple message on the economy is what carried him to victory.) Harris made abortion a centerpiece of her campaign and lost, but voters in seven states passed ballot referenda protecting abortion rights—some in blue states, but also in purple and red states including Arizona, Nevada, and Montana. Missouri voters overturned an abortion ban. And 57 percent of Floridians supported a ballot issue, a number that nonetheless fell short of the 60 percent required for passage. A majority, but not the requisite supermajority, of Floridians also voted to legalize recreational cannabis use. Even in U.S. Senate races, Democratic candidates ran ahead of Harris in almost every competitive contest. (Florida was the odd race out.)

That mixed result is also a mixed message for Democrats trying to figure out where the party goes from here. Having a reasonably popular policy platform is theoretically good news for them, but that isn’t much use if they can’t win the offices required to institute or defend those policies. But with little real power in Washington for the next two years, they’ll have plenty of time to think about the conundrum.